International Journal of Infectious Diseases (Nov 2020)

Case studies of SARS-CoV-2 treated with favipiravir among patients in critical or severe condition

  • Hidenori Takahashi,
  • Yoshinobu Iwasaki,
  • Takayasu Watanabe,
  • Naoki Ichinose,
  • Yasusei Okada,
  • Akito Oiwa,
  • Takehiro Kobayashi,
  • Mariko Moriya,
  • Toshimi Oda

Journal volume & issue
Vol. 100
pp. 283 – 285

Abstract

Read online

• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is spreading globally. However, clinically effective antiviral treatments are not established. Favipiravir may prevent pneumonia and acute respiratory distress syndrome aggravation. We describe SARS-CoV-2-positive patients, two of whom were in a critical condition and one of whom was in a severe condition, who were administered favipiravir for their deteriorating conditions and were cured.

Keywords